Gold down on COVID-19 news
Gold has fallen 0.16% following the U.S. pharmaceutical company - Pfizer’s announcement that results from the early stage human trial for BNT162b1, jointly developed with the German biotech firm BioNTech, showed production of neutralizing antibodies in all the patients who were inoculated after 28 days.
As hopes for the coronavirus cure loom, investors are looking to leaving safe-haven and developing appetites for riskier investments.
Analysts, warn, however, that this may not be the last we see of gold. As the number of COVID-19 cases continues to rise, the re-instatement of lockdown measures may be required. The WHO forecast of “the worst is yet to come” is too hardly comforting.
The number of cases has now surpassed the 10.6 million mark, according to data from Johns Hopkins University, so it’s only expected investors will rush back to safe-haven assets sooner than we know,.
*The products advertised are only available to clients under Fondex Limited Seychelles (SDL No: SD037).
Cookies on Fondex
These cookies fall under the following categories: essential, functional and marketing cookies. Marketing cookies may also include third-party cookies.
You can customize your selection of which cookies you want to accept.
These cookies are necessary for the website to function correctly and cannot be switched off.
Functional cookies allow the website to remember users' preferences and the choices you make on the website such as username, region, and language.